CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an announcement.
CSPC Pharmaceutical Group Limited has announced its upcoming annual general meeting scheduled for May 30, 2025, where key agenda items include the approval of financial statements, declaration of a final dividend, re-election of directors, and re-appointment of auditors. Additionally, the company seeks shareholder approval for a share buyback program, allowing the directors to repurchase up to 10% of the company’s issued shares, which could impact shareholder value and market perception.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating within the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products.
YTD Price Performance: 7.74%
Average Trading Volume: 35,356
Technical Sentiment Signal: Buy
Current Market Cap: $9.08B
For a thorough assessment of 1093 stock, go to TipRanks’ Stock Analysis page.